Correlia Biosystems
PrivateLast Round
Series A
Extension
May 9, 2023
Est. Valuation
$1.71M
Total Funding Raised
$9.47M
Company Overview
Correlia Biosystems is a life sciences company that develops and manufactures proteomic tools and automated immunoassay platforms designed to accelerate the quantification of biomolecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Correlia Biosystems Comparables
Compare Correlia Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spear Bio | 81% | |
| Quansys Biosciences | 77% | |
| Bio-Techne Corporation | 76% |
For institutional investors. Book with your work email.
Correlia Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 9, 2023 | ||||
| Series A | Nov 20, 2020 | ||||
| Grant | Jan 29, 2020 | ||||
| Accelerator | Jan 1, 2018 | ||||
| Grant | Sep 13, 2016 | ||||
Grant | Aug 4, 2014 |
For institutional investors. Book with your work email.
Correlia Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of California | Series A |
| Cota Capital | Series A |
| NIH RADx | Grant |
| Y Combinator | Accelerator |
| Neotribe Ventures | Series A |
| National Institute of General Medical Sciences | Grant |
| National Science Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2016
$874K grant from National Science Foundation and NIH RADx.
For institutional investors. Book with your work email.
Correlia Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Correlia Biosystems's valuation, stock price, and market status.
Is Correlia Biosystems a public or private company?
Correlia Biosystems is a private company.
What is the current stock price of Correlia Biosystems?
Correlia Biosystems is a private company, so its shares have no public market price. Caplight tracks Correlia Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Correlia Biosystems worth (valuation)?
Correlia Biosystems's valuation is estimated at $1.7M based on funding round data.
Can I buy Correlia Biosystems stock?
Correlia Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Correlia Biosystems's last funding round?
Correlia Biosystems's most recent funding round was Series A Extension on May 9, 2023.
Who are the main investors in Correlia Biosystems?
Key investors in Correlia Biosystems include Neotribe Ventures.
Will Correlia Biosystems IPO soon?
No public IPO plans have been announced for Correlia Biosystems.
How can I track Correlia Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Correlia Biosystems's shares on secondary markets.